#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Monogenic diabetes Alveolar proteinosis Paraneoplastic neurological syndrome Ewing's sarcoma metastatic Heart disease congenital Phenylketonuria Juvenile chronic myelomonocytic leukaemia Facioscapulohumeral muscular dystrophy Glomerulonephritis acute Renal disorder Essential thrombocythaemia Palmar-plantar erythrodysaesthesia syndrome Arterial disorder Neoplasm malignant Non-small cell lung cancer metastatic More trials…

    Learn about Rare Diseases

    Synovial sarcoma recurrent Systemic sclerosis pulmonary – Basic Information Factor IX deficiency – Life with Disease Leiomyosarcoma recurrent – Treatment Mucopolysaccharidosis III – Diagnostics Undifferentiated sarcoma – Basic Information Glomerulonephritis membranoproliferative – Trials in Disease Glycogen storage disease type I – Diagnostics Lymphangioma – Treatment Small intestine leiomyosarcoma – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Ag-946 Phosphate Tertomotide Nusinersen Calcium Lactate Gluconate VHB937 PETHIDINE HYDROCHLORIDE SARACATINIB Danicamtiv Cenobamate Tiaprofenic Acid Octocog Alfa Eribulin Amsacrine Losartan Potassium Clioquinol Potassium Iodide Lenvatinib Minoxidil Bortezomib Lomustine More therapies…

    Learn about Your Condition

    Psychogenic seizure Coagulopathy Inborn error of metabolism Cardiac failure Acute hepatic failure Stevens-Johnson syndrome Acquired ATTR amyloidosis Decreased appetite Rectosigmoid cancer Brain cancer metastatic Colorectal adenocarcinoma Marginal zone lymphoma Monkeypox Hyperglycaemia Renal transplant More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Digestive System and Oral Physiological Phenomena

  • Study on the Effects of Bezafibrate and Obeticholic Acid for Patients with Primary Biliary Cholangitis

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Primary biliary cholangitis
    Investigated Drugs:
    • Bezafibrate
    • Obeticholic Acid
    Italy

  • Study of Setmelanotide for Patients with Obesity Due to Specific Genetic Variants

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Obesity
    Investigated Drugs:
    • Setmelanotide
    France Germany Greece The Netherlands Spain

  • Study on Long-Term Safety of Cendakimab for Adults and Adolescents with Eosinophilic Esophagitis

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Eosinophilic oesophagitis
    Investigated Drugs:
    • Cendakimab
    Austria Belgium Germany Italy Poland Portugal +1

  • Study of Capivasertib and Abiraterone for Patients with Metastatic Hormone-Sensitive Prostate Cancer with PTEN Deficiency

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Hormone-dependent prostate cancer
    Investigated Drugs:
    • Capivasertib
    • Abiraterone Acetate
    Belgium Bulgaria Czechia France Germany The Netherlands +3

  • Study on Golexanolone for Patients with Primary Biliary Cholangitis Experiencing Fatigue and Cognitive Dysfunction

    Not recruiting

    1 1
    Investigated Diseases:
    • Primary biliary cholangitis
    Investigated Drugs:
    • Golexanolone
    Germany Greece Hungary Italy Spain
Previous Page
1 2 3

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!